# A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

> **NCT01059643** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 103 (actual)

## Conditions studied

- Ovarian Cancer
- Non Small Cell Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Gastric Cancer
- Esophageal Cancer
- Cancer of Head and Neck

## Interventions

- **DRUG:** LY2523355
- **DRUG:** pegfilgrastim

## Key facts

- **NCT ID:** NCT01059643
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059643, "A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01059643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*